Happydemics, a Paris-based adtech company specializing in brand metrics and performance measurement, has secured €13 million in a Series B funding round.
The round was led by Wille Finance and Adelie Capital and will support Happydemics’ expansion into the UK and other international markets while advancing its AI-driven solutions.
Revolutionizing Ad Performance Measurement
Founded in 2015 by Tarek Ouagguini, Happydemics provides a comprehensive platform for measuring and optimizing media investments across multiple channels, including OOH, CTV, audio, and in-game advertising. The platform offers insights across 25,000 performance criteria, eliminating blind spots for advertisers.
Happydemics’ flagship Brand Lift solution has been used by over 2,000 advertisers in 60 countries, enabling them to assess the effectiveness of multichannel campaigns.
Tarek Ouagguini, CEO, emphasized the company’s mission: “We deliver precise, actionable insights to optimize ad campaigns, proving their effectiveness and ensuring advertisers achieve better returns on ad spend.”
Strategic Growth Plans
The funding will bolster Happydemics’ efforts to:
- Expand into the UK and strengthen its presence in the US and Europe.
- Advance AI-driven predictive capabilities to optimize campaign outcomes.
- Forge new partnerships with major industry players like The Trade Desk, ITV, and GroupM.
Backing from Key Investors
- Cyril Petit, Investment Director at Wille Finance, stated: “Happydemics’ innovative solutions simplify ad performance measurement, giving marketers a strategic edge in optimizing their campaigns.”
- Jean-Manuel Costa, Managing Partner at Adelie Capital, added: “Happydemics is establishing itself as a trusted third party for brands and adtech players, driving global expansion with this new round of funding.”
Driving the Future of Adtech
With this investment, the company is poised to set a global standard for ad performance measurement, helping brands and agencies achieve better results in an increasingly complex advertising landscape.